CS241069B2 - Method of 4"-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycine a preparation - Google Patents

Method of 4"-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycine a preparation Download PDF

Info

Publication number
CS241069B2
CS241069B2 CS838455A CS845583A CS241069B2 CS 241069 B2 CS241069 B2 CS 241069B2 CS 838455 A CS838455 A CS 838455A CS 845583 A CS845583 A CS 845583A CS 241069 B2 CS241069 B2 CS 241069B2
Authority
CS
Czechoslovakia
Prior art keywords
aza
deoxo
methyl
compound
epi
Prior art date
Application number
CS838455A
Other languages
Czech (cs)
English (en)
Other versions
CS845583A2 (en
Inventor
Gene M Bright
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to CS847926A priority Critical patent/CS241099B2/cs
Publication of CS845583A2 publication Critical patent/CS845583A2/cs
Publication of CS241069B2 publication Critical patent/CS241069B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
CS838455A 1982-11-15 1983-11-15 Method of 4"-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycine a preparation CS241069B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS847926A CS241099B2 (cs) 1982-11-15 1983-11-15 Způsob přípravy 4“-epi-9-deoxo-9a-methyl-9a-aza- -9a-bomoerythromycinu A

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44197982A 1982-11-15 1982-11-15

Publications (2)

Publication Number Publication Date
CS845583A2 CS845583A2 (en) 1985-07-16
CS241069B2 true CS241069B2 (en) 1986-03-13

Family

ID=23755068

Family Applications (1)

Application Number Title Priority Date Filing Date
CS838455A CS241069B2 (en) 1982-11-15 1983-11-15 Method of 4"-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycine a preparation

Country Status (26)

Country Link
EP (1) EP0109253B1 (el)
JP (1) JPS59104398A (el)
KR (1) KR850000968B1 (el)
AT (1) ATE30237T1 (el)
AU (1) AU544790B2 (el)
CA (1) CA1239639A (el)
CS (1) CS241069B2 (el)
DD (1) DD216017A5 (el)
DE (1) DE3374065D1 (el)
DK (1) DK159322C (el)
EG (1) EG16641A (el)
ES (2) ES8600327A1 (el)
FI (1) FI72980C (el)
GR (1) GR79425B (el)
GT (1) GT198304062A (el)
HU (1) HU193886B (el)
IE (1) IE56234B1 (el)
IL (1) IL70228A (el)
NO (1) NO160262C (el)
NZ (1) NZ206259A (el)
PH (2) PH19293A (el)
PL (2) PL142601B1 (el)
PT (1) PT77645B (el)
SU (1) SU1272996A3 (el)
YU (2) YU43198B (el)
ZA (1) ZA838460B (el)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE38519T1 (de) * 1983-09-06 1988-11-15 Pfizer Azahomoerythromycin-b-derivate und zwischenprodukte.
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
SI8911498B (sl) * 1989-07-26 1998-10-31 Pliva Postopek za pripravo derivatov tilozina
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
CA2064985A1 (en) * 1991-04-05 1992-10-06 Robert R. Wilkening 8a-aza-8a-homoertyhromycin cyclic lactams
CA2065222A1 (en) * 1991-04-09 1992-10-10 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
EP0508795A1 (en) * 1991-04-10 1992-10-14 Merck & Co. Inc. 8a-aza-8a-homoerythromycin cyclic iminoethers
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
CA2065218A1 (en) * 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
CA2068951A1 (en) * 1991-05-20 1992-11-21 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic lactams
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
MX9605419A (es) * 1994-05-06 1997-12-31 Pfizer Formas de dosificacion de liberacion controlada de azitromicina.
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
DK1206476T3 (da) * 1999-08-24 2006-05-15 Abbott Lab 9a-azalider med antibakteriel virkning
WO2001049697A1 (en) * 2000-01-04 2001-07-12 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
JP2004506664A (ja) 2000-08-23 2004-03-04 ウォックハート・リミテッド 無水アジトロマイシンの製造法
US6852262B2 (en) 2002-05-09 2005-02-08 The Gillette Company Insert molding razor cartridges
CA2547597A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
JP2007513145A (ja) 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 医薬用多微粒子の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
JPS5788193A (en) * 1980-11-21 1982-06-01 Pliva Pharm & Chem Works 11-aza-10-deoxo-10-dihydroerythromycin a, derivatives and manufacture
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents

Also Published As

Publication number Publication date
PL244557A1 (en) 1985-03-26
ES8604257A1 (es) 1986-01-16
NO834146L (no) 1984-05-16
FI72980B (fi) 1987-04-30
PH21560A (en) 1987-12-11
ES527249A0 (es) 1985-10-01
DK159322B (da) 1990-10-01
DD216017A5 (de) 1984-11-28
KR840006673A (ko) 1984-12-01
AU544790B2 (en) 1985-06-13
IL70228A (en) 1987-03-31
EG16641A (en) 1990-08-30
YU224383A (en) 1986-04-30
DK518683D0 (da) 1983-11-14
PL142601B1 (en) 1987-11-30
DK159322C (da) 1991-02-25
PT77645A (en) 1983-12-01
IE56234B1 (en) 1991-05-22
IL70228A0 (en) 1984-02-29
FI834163A (fi) 1984-05-16
EP0109253A3 (en) 1984-09-12
HU193886B (en) 1987-12-28
JPS59104398A (ja) 1984-06-16
SU1272996A3 (ru) 1986-11-23
NO160262C (no) 1989-03-29
YU43425B (en) 1989-06-30
ZA838460B (en) 1985-06-26
IE832652L (en) 1984-05-15
NO160262B (no) 1988-12-19
CA1239639A (en) 1988-07-26
PH19293A (en) 1986-03-04
GT198304062A (es) 1985-05-04
PL250350A1 (en) 1985-04-24
GR79425B (el) 1984-10-22
JPH0140038B2 (el) 1989-08-24
DK518683A (da) 1984-05-16
NZ206259A (en) 1986-08-08
FI834163A0 (fi) 1983-11-14
ES8600327A1 (es) 1985-10-01
CS845583A2 (en) 1985-07-16
PT77645B (en) 1986-05-12
FI72980C (fi) 1987-08-10
YU43198B (en) 1989-04-30
YU197285A (en) 1986-08-31
EP0109253B1 (en) 1987-10-14
ES543638A0 (es) 1986-01-16
PL143281B1 (en) 1988-01-30
ATE30237T1 (de) 1987-10-15
HUT35273A (en) 1985-06-28
AU2130983A (en) 1984-05-24
DE3374065D1 (en) 1987-11-19
KR850000968B1 (ko) 1985-07-02
EP0109253A2 (en) 1984-05-23

Similar Documents

Publication Publication Date Title
CS241069B2 (en) Method of 4"-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycine a preparation
US4474768A (en) N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
DK172636B1 (en) 6-o-methylerythromycin a derivative
RU2192427C2 (ru) Производные эритромицина, обладающие антибактериальной активностью, способ их получения (варианты), фармацевтическая композиция и способ регулирования бактериальной инфекции у млекопитающего
RU2045533C1 (ru) О-метильные производные азитромицина а, обладающие антибактериальной активностью, азитромицины в качестве промежуточных соединений для получения о-метильных производных азитромицина а и способ получения о-метильных производных азитромицина а
US4526889A (en) Epimeric azahomoerythromycin A derivative, intermediates and method of use
CZ303474B6 (cs) 6-O-substituovaný ketolidový derivát erythromycinu, zpusob jeho prípravy, jeho použití a farmaceutická kompozice ho obsahující
HU198913B (en) Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
HU193157B (en) Process for preparing 4"-epi-erythromycin a and derivatives thereof
US4150220A (en) Semi-synthetic 4"-erythromycin A derivatives
JPH0692434B2 (ja) ９−デオキソ−８ａ−アザ−８ａ−アルキル−８ａ−ホモエリスロマイシンＡの４″誘導体の製造方法
EP0136831A2 (en) Azahomoerythromycin B derivatives and intermediates thereof
CA2196878A1 (en) Interleukin-5 production inhibitor
EP0508726A1 (en) Novel process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
EP0508725A1 (en) Novel process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
JPS5827799B2 (ja) ４″−アミノ−オレアンドマイシン誘導体
AU616316B2 (en) New tylosin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
PL116228B1 (en) Process for preparing novel derivatives of 4"-desoxyaminoerythromycin a"
CS241099B2 (cs) Způsob přípravy 4“-epi-9-deoxo-9a-methyl-9a-aza- -9a-bomoerythromycinu A
HU196823B (en) Process for producing n-hydroxy-11-aza-10-deoxo-10-dihydro-erythromycin-a-n'-oxide
CA1250284A (en) Antibacterial epimeric azahomoerythromycin a derivative and production thereof
EP0508795A1 (en) 8a-aza-8a-homoerythromycin cyclic iminoethers
KR850000963B1 (ko) N-메틸 11-아자-10-데옥소-10-디하이드로 에리스로마이신 a 및 그 중간체의 제조방법
JPH10330393A (ja) 新規なセコマクロライド及びその製造方法
MXPA98009308A (en) Derivatives of 3-descladinosa-2, 3-anhydroeritromic